| For: | Yu LC, Li YP, Xin YM, Mao M, Pan YX, Qu YX, Luo ZD, Zhang Y, Zhang X. Application of Fusobacterium nucleatum as a biomarker in gastrointestinal malignancies. World J Gastrointest Oncol 2024; 16(6): 2271-2283 [PMID: 38994170 DOI: 10.4251/wjgo.v16.i6.2271] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v16/i6/2271.htm |
| Number | Citing Articles |
| 1 |
Zhenlu Wang, Xinran Long, Muzi Zhang, Ming Li, Jian Shao, Changan Wang, Lei Gan, Jiangfeng Chen, Ming Wen, Chuanjie Qin, Haibo Jiang. Amelioration of ammonia‐induced oxidative stress, ferroptosis and intestinal damage in Pelteobagrus fulvidraco through dietary tea polyphenols. Journal of Fish Biology 2026; doi: 10.1111/jfb.70362
|
| 2 |
Yvonne Prince, Glenda Mary Davison, Tandi Matsha, Shanel Raghubeer. The Role of Fusobacterium in Periodontal Disease and Its Implications for Cardiovascular Health. Biomedicines 2026; 14(3) doi: 10.3390/biomedicines14030697
|
| 3 |
Tyler Halverson, Kannayiram Alagiakrishnan. The Brain-Gut-Microbiome Axis Across the Life Continuum and the Role of Microbes in Maintaining the Balance of Health. Journal of Integrative Neuroscience 2025; 24(8) doi: 10.31083/JIN36616
|
| 4 |
Shriyans Reddy Yendreddy, Divya Patchigolla, Satyendra Singh, Kirti Baghel, Rupal Ojha, Vijay Kumar Prajapati. Immunomodulators - Part B. Advances in Protein Chemistry and Structural Biology 2026; 152 doi: 10.1016/bs.apcsb.2025.10.008
|
| 5 |
Chengxu Guo, Caixia Wang. Microbiota-host metabolism reprogramming in colorectal cancer: from pathogenesis to precision therapies. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1713614
|
| 6 |
Darab Ghadimi, Sophia Blömer, Aysel Şahin Kaya, Sandra Krüger, Christoph Röcken, Heiner Schäfer, Jumpei Uchiyama, Shigenobu Matsuzaki, Wilhelm Bockelmann. Assessing the role of folate syntrophy and folate cross-feeding in the pathobiology of infectious-inflamed milieu caused by Fusobacterium nucleatum. Experimental and Molecular Pathology 2026; 145 doi: 10.1016/j.yexmp.2025.105021
|
| 7 |
Xiaoxuan Liu, Shan Liu, Zhi Guo. Research advances in the correlation between oral microbiota and tumors. Holistic Integrative Oncology 2026; 5(1) doi: 10.1007/s44178-026-00270-z
|
| 8 |
Stanisław Krokosz, Maria Obrycka, Anna Zalewska. Can Salivary Biomarkers Serve as Diagnostic and Prognostic Tools for Early Detection in Patients with Colorectal Cancer? A Systematic Review. Current Issues in Molecular Biology 2025; 47(8) doi: 10.3390/cimb47080647
|
| 9 |
Asma Bachir, Alaa Muayad Altaie, Riyad Bendardaf, Iman M. Talaat, Rifat Hamoudi. Microbial dysbiosis drives colorectal carcinogenesis via integrated inflammatory, metabolic, and biofilm pathways. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1795882
|
| 10 |
Shriyansh Srivastava, Sachin Kumar. Microbial oncogenesis: the impact of Fusobacterium nucleatum on oral cancer pathways. Medical Oncology 2025; 43(1) doi: 10.1007/s12032-025-03150-0
|
| 11 |
Kateryna Maslova, Magdalena Chechlinska, Irmina Maria Michalek, Lukasz Taraszkiewicz, Paulina Kober, Inga Trulson, Karolina Worf, Sophie Gabriel, Laura Knoblauch, Fiona Campbell, Ian A. Cree, Stefan Holdenrieder, Magdalena Kowalewska. Tumour markers and evidence-based pathology. Tumor Biology 2026; 48 doi: 10.1177/14230380251410478
|